clarithromycin has been researched along with Experimental Lung Inflammation in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 24 (26.67) | 18.2507 |
2000's | 37 (41.11) | 29.6817 |
2010's | 25 (27.78) | 24.3611 |
2020's | 4 (4.44) | 2.80 |
Authors | Studies |
---|---|
Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D | 1 |
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
Domon, H; Hirayama, S; Hiyoshi, T; Isono, T; Maekawa, T; Sasagawa, K; Tamura, H; Terao, Y; Yanagihara, K | 1 |
Alharbi, L; Alkhamisi, R; Alradadi, R; Ashy, N; Eljaaly, K | 1 |
Karpova, OY; Pigusova, NA; Rachina, SA; Sinopalnikov, AI; Vasilyeva, IS | 1 |
Hara, K; Hiramatsu, K; Ichimiya, T; Imamura, Y; Kadota, JI; Kishi, K; Koga, H; Kohno, Y; Komiya, K; Mukae, H; Noguchi, S; Otani, S; Shigenaga, T; Tanaka, H; Yamasue, M; Yatera, K; Yoshikawa, H | 1 |
Chambers, ST; Doogue, MP; Gardiner, SJ; Metcalf, SC; Werno, A | 1 |
Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K | 1 |
Byrne, AL; Chai, KY; Morison, IM | 1 |
Grindrod, KA; Nagge, J | 1 |
Chai, CY; Chen, IJ; Chung, PW; Huang, HT; Kuo, MS; Liu, CP; Wu, BN | 1 |
Akram, A; Chalmers, JD; Hill, AT; Schembri, S; Short, PM; Singanayagam, A; Taylor, J; Williamson, PA | 1 |
Gibbins, NE; Hopkins, C; Theokli, C | 1 |
Colombo, G; Haghi, M; King, G; Saadat, A; Traini, D; Young, PM; Zhu, B | 1 |
Bansal, S; Chhibber, S | 1 |
Bienias, P; Ciurzyński, M; Paczyńska, M; Pruszczyk, P | 1 |
Arnold, RD; Berghaus, LJ; Burton, AJ; Giguère, S; Hondalus, MK | 1 |
Goto, H; Honda, K; Inui, T; Ishii, H; Kamma, H; Kurai, D; Nakamoto, K; Nakamura, M; Sada, M; Saraya, T; Takata, S; Takizawa, H; Wada, H; Watanabe, M; Yokoyama, T | 1 |
Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
Akinci, E; Aygencel, G; Bildik, F; Demircan, A; Kara, PH; Ozsarac, M | 1 |
Chhibber, S; Harjai, K; Kumar, V | 1 |
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
Banal, F; Cinquetti, G; Genest, A; Graffin, B; Lemant-Pluvinage, N; Mohamed, S; Noisette, P; Salles, Y; Wannin, J | 1 |
Giamarellos-Bourboulis, EJ | 1 |
Hirai, T; Kikuchi, R; Matsukura, T; Mino, N; Okamoto, T | 1 |
Gawlikowski, T; Groszek, B; Hydzik, P | 1 |
Chojin, Y; Ishii, H; Kadota, J; Komiya, K; Mukae, H; Yamagata, E; Yamamoto, H; Yatera, K | 1 |
Eiznhamer, DA; English, ML; Flavin, MT; Fredericks, CE; Jenta, TR; Milanesio, NA; Rohowsky, N; Xu, ZQ | 1 |
Gumber, MR; Kute, VB; Patel, HV; Patel, MP; Patil, SB; Shah, PR; Shrimali, JD; Trivedi, HL; Vanikar, AV | 1 |
Al-Abri, SS; Al-Maashani, S; Beeching, NJ; Memish, ZA | 1 |
Bayles, T; Cheng, AC; Choo, S; Tong, E | 1 |
Akermanis, M; Dimiņa, E; Dumpis, U; Tirāns, E; Veide, S | 1 |
Henrion, E; Lepage, P; Trippaerts, M | 1 |
Eriksson, U; Heim, MH; Krähenbühl, S; Marsch, S; Terracciano, L; Tietz, A | 1 |
Corris, P; Duprat-Lomon, I; Höffken, G; Kubin, R; Muir, JF; Sagnier, PP; Torres, A | 1 |
Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY | 1 |
Chang, J; Cots, JM; Domínguez-Gil, A; Herreras, A; Rubio-Terrés, C; Sánchez Gascón, F; Trilla, A | 1 |
Hassman, J; Mathers Dunbar, L; Tellier, G | 1 |
Demartini, G; Esposti, D; Fraschini, F; Lapidari, A; Marthyn, P; Scaglione, F | 1 |
Martínez-Vázquez, C; Rodríguez-Suárez, JR; Sabrià, M; Segura, F; Sopena, N; Valencia, A | 1 |
Asche, CV; Chang, JR; Lavin, B; Stewart, J; Sullivan, SD; Tellier, G | 1 |
Chang, JR; Niederman, MS; Nieman, RB; Nusrat, R; Stewart, J | 1 |
Carriere, KC; Jin, Y; Johnson, D; Marrie, T | 1 |
Lavin, B; Niederman, MS; Nusrat, R; Patel, M; Tellier, G | 1 |
Aurangzeb, B; Hameed, A | 1 |
Chakrabarti, S; Chouhan, UM; Millward, LJ | 1 |
Breen, JD; De Salvo, MC; Drehobl, MA; Lewis, DE | 1 |
Bestry, I; Langfort, R; Radzikowska, E; Roszkowski, K; Rudziński, P; Wiatr, E | 1 |
Díaz F, A; Pavié G, J; Prida C, JM; Saldías P, F | 1 |
Blasi, F; Tarsia, P | 1 |
Albrecht, JE; Gair, RD; Glezos, JD | 1 |
Erni, S; Fliegner, M; Zink, A | 1 |
Blasi, F; de Caprariis, PJ; Feldman, C; Garbino, J; Hoepelman, IM; Hogan, P; Tamm, M; Todisco, T | 1 |
Abu-Laban, RB; Boudreaux, ED; Camargo, CA; Campbell, SG; Clark, S; Colman, I; Rowe, BH; Sivilotti, ML | 1 |
Freudenberger, R; Mahal, M; Mateo-Bibeau, R; Naik, S; Shinnar, M | 1 |
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
Chen, JM; Huang, LM; Lee, CY; Lee, PI; Wu, MH | 1 |
Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R | 1 |
Sharma, PK; Tami, TA | 1 |
Echávarri, B; Marco, ML; Remacha, A | 1 |
Parent, M | 1 |
Bradbury, F | 1 |
Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
Chan, CK; Chien, SM; Pichotta, P; Siepman, N | 1 |
Monteforte, JS; Wood, CA | 1 |
Kaneko, S; Ohkubo, T; Otani, K; Shimoyama, R; Sugawara, K; Yasui, N | 1 |
Craft, JC; Fätkenheuer, G; Jablonowski, H; Lines, S; Newell, T; Youle, M | 1 |
Gunawan, J; Mangunnegoro, H; Soepandi, P; Yunus, F | 1 |
Krediet, RT; van Westrhenen, R; Weening, JJ | 1 |
Piquette, RK | 1 |
Carrión Valero, F; Gómez Cubillos, C; Pascual Izuel, JM | 1 |
Allan, GS; Davis, W; Foster, SF; Malik, R; Martin, P; Mitchell, DH | 1 |
Goldberg, EI; Sapadin, AN; Shoji, T | 1 |
Huchon, G | 1 |
Ali, A; Awad, CE; Dainesi, SM; Matyas, R; Nakatani, J; Rocha, RT; Salazar, MS; Silva, CO; Vital, AC | 1 |
Dell'Orso, D; Parola, D; Terzano, C | 1 |
Goss, TF; Najib, MM; Stein, GE | 1 |
Hatipoglu, ON; Tasan, Y | 1 |
Harada, M; Kataoka, M; Kawata, N; Matsuo, K; Nabe, M; Okamoto, M; Tada, S; Takeuchi, M; Yamadori, I | 1 |
Prescott, LM | 1 |
Konishi, Y; Mikasa, K; Murakawa, Y; Murata, N; Narita, N; Sasaki, Y; Tsujiuchi, T; Tsutsumi, M | 1 |
Hoeffken, G; Meyer, HP; Verhoef, L; Winter, J | 1 |
Acampora, MD; Busman, TA; Notario, GF; Sokol, WN; Sullivan, JG | 1 |
Busman, TA; Dattani, D; Devcich, KJ; Gotfried, MH; Notario, GF; Palmer, RN; Riffer, E | 1 |
Berk, SL | 1 |
Poirier, R | 1 |
Anderson, G; Carnegie, C; Coles, S; Esmonde, TS; Macklin, J | 1 |
Delaval, P; Desrues, B; Kernec, J; Le Coz, A; Lineau, C; Prigent, JM; Quinquenel, ML; Ramee, MP | 1 |
5 review(s) available for clarithromycin and Experimental Lung Inflammation
Article | Year |
---|---|
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Pneumonia; Randomized Controlled Trials as Topic | 2022 |
Simplifying QT prolongation for busy clinicians.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Family Practice; Female; Humans; Long QT Syndrome; Male; Pneumonia; Risk Assessment; Risk Factors; Torsades de Pointes | 2019 |
Macrocycle molecules for the management of systemic infections: the clarithromycin paradigm.
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Macrolides; Pneumonia; Retrospective Studies; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
Value of short-course antimicrobial therapy in community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Microspheres; Ofloxacin; Pneumonia; Time Factors; Treatment Outcome | 2005 |
AIDS: lessons from the last decade and prospects for the future.
Topics: Acquired Immunodeficiency Syndrome; Blood Transfusion; Clarithromycin; HIV Seropositivity; Humans; Mycobacterium Infections; Pneumocystis; Pneumonia; Sexual Behavior; Substance-Related Disorders; Trimethoprim; Zidovudine | 1995 |
27 trial(s) available for clarithromycin and Experimental Lung Inflammation
Article | Year |
---|---|
Effect of long-term clarithromycin therapy on prevention of pneumonia in older adults: A randomized, controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Male; Pneumonia; Prospective Studies | 2019 |
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Endpoint Determination; Ethnicity; Female; Humans; Ketolides; Male; Middle Aged; Pneumonia; Sex Factors; Treatment Outcome; Young Adult | 2012 |
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Penicillins; Pneumonia; Quinolines | 2003 |
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia | 2003 |
Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia | 2004 |
Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-6; Male; Middle Aged; Penicillins; Pneumonia | 2004 |
Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pneumonia; Prospective Studies | 2004 |
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Hospitalization; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia; Treatment Outcome | 2004 |
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Hospitalization; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia; Treatment Outcome | 2004 |
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Bacterial; Electrocardiography; Enzyme Induction; Female; Haemophilus influenzae; Humans; Ketolides; Liver Function Tests; Macrolides; Male; Middle Aged; Moraxella catarrhalis; Pneumonia; Sample Size; Sputum; Streptococcus pneumoniae; Treatment Outcome | 2004 |
Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Female; Humans; Infant; Length of Stay; Male; Pneumonia; Time Factors | 2003 |
Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Microspheres; Middle Aged; Pneumonia | 2005 |
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Random Allocation; Treatment Outcome | 2007 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Mycoplasma Infections; Pneumonia; Treatment Outcome | 2008 |
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae | 1995 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1993 |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Canada; Child; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Pneumonia; Sweden; Tablets | 1993 |
Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Female; Giardia lamblia; Giardiasis; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumocystis; Pneumonia; Pneumonia, Pneumocystis; Sarcoma, Kaposi | 1997 |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Bronchitis; Clarithromycin; Female; Humans; Klebsiella pneumoniae; Male; Pneumonia; Respiratory Tract Infections; Specimen Handling; Sputum; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1998 |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia; Spiramycin | 1999 |
A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Male; Pneumonia; Radiography, Thoracic; Roxithromycin | 2000 |
The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Confidence Intervals; Double-Blind Method; Female; Fluoroquinolones; Humans; Liver Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia; Prospective Studies; Quinolines; Recurrence; Treatment Outcome | 2001 |
A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; Pneumonia; Prospective Studies; Radiography; Treatment Outcome | 2002 |
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome | 2002 |
Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Remission Induction; Roxithromycin | 1991 |
A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
58 other study(ies) available for clarithromycin and Experimental Lung Inflammation
Article | Year |
---|---|
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2009 |
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.
Topics: Animals; Anti-Bacterial Agents; Bronchioles; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Chemokine CXCL2; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-1beta; Male; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia; Pulmonary Alveoli | 2010 |
Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Down-Regulation; Erythromycin; Humans; Lincosamides; Male; Mice; Mice, Inbred BALB C; Pneumonia; Protein Synthesis Inhibitors; Streptococcus pneumoniae; Streptolysins; Transcription, Genetic | 2021 |
[Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Clarithromycin; Community-Acquired Infections; Female; Humans; Interleukin-6; Male; Middle Aged; Pneumonia; Tumor Necrosis Factor-alpha; Young Adult | 2023 |
A persuasive approach to antimicrobial stewardship in Christchurch hospitals produced a sustained decrease in intravenous clarithromycin dosing and expenditure via a switch to azithromycin orally.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Clarithromycin; Community-Acquired Infections; Dosage Forms; Guideline Adherence; Hospitals; Humans; New Zealand; Pneumonia | 2020 |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir | 2017 |
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Multiple Myeloma; Pneumonia; Roxithromycin; Treatment Outcome | 2018 |
NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis.
Topics: Animals; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Piperidines; Pneumonia; Pulmonary Fibrosis; Signal Transduction; Simvastatin; Time Factors; Xanthines | 2014 |
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Disease Progression; Female; Follow-Up Studies; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Pneumonia; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; United Kingdom | 2013 |
Time to reconsider guidelines on clarithromycin in chronic rhinosinusitis?
Topics: Acute Coronary Syndrome; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Male; Pneumonia | 2013 |
The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Chemistry, Pharmaceutical; Clarithromycin; Drug Delivery Systems; Drug Stability; Macrolides; Metered Dose Inhalers; Particle Size; Pneumonia; Pulmonary Disease, Chronic Obstructive; Solutions | 2014 |
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Malondialdehyde; Mice, Inbred BALB C; Nitric Oxide; Peroxidase; Pneumonia; Tumor Necrosis Factor-alpha | 2014 |
Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clarithromycin; Drug Therapy, Combination; Electrocardiography; Heart Arrest; Humans; Long QT Syndrome; Male; Middle Aged; Pneumonia; Pulmonary Edema; Torsades de Pointes; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Gentamicins; Horse Diseases; Horses; Liposomes; Liver; Macrophages, Alveolar; Male; Mice; Mice, Nude; Pneumonia; Rhodococcus equi; Rifampin; Spleen | 2015 |
Clarithromycin ameliorates pulmonary inflammation induced by short term cigarette smoke exposure in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Clarithromycin; Cytokines; Female; Lung; Mice; Mice, Inbred C57BL; Nicotiana; Pneumonia; Smoke; Tobacco Products | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Focal mass-like opacity on chest radiography: round pneumonia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Pneumonia; Tomography, X-Ray Computed | 2010 |
Effect of clarithromycin on lung inflammation and alveolar macrophage function in Klebsiella penumoniae B5055-induced acute lung infection in BALB/c mice.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Klebsiella Infections; Klebsiella pneumoniae; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Nitric Oxide; Peroxidase; Pneumonia | 2008 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
[Rare complications of Lemierre's syndrome: septic sternoclavicular joint arthritis and cavitating pneumonia].
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Clarithromycin; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Jugular Veins; Male; Pneumonia; Rare Diseases; Severity of Illness Index; Sternoclavicular Joint; Syndrome; Treatment Outcome; Upper Extremity Deep Vein Thrombosis | 2009 |
A case of Good's syndrome: a rare acquired immunodeficiency associated with thymoma.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Common Variable Immunodeficiency; Humans; Male; Neoplasms, Glandular and Epithelial; Pneumonia; Recurrence; Sinusitis; Thymectomy; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Drug-induced erythrodermia complicated by multiorgan failure--case report].
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dermatitis, Exfoliative; Female; Humans; Ibuprofen; Liver Failure, Acute; Multiple Organ Failure; Pneumonia | 2011 |
Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection.
Topics: Adult; Antiviral Agents; Clarithromycin; Female; Humans; Influenza A virus; Influenza, Human; Male; Pneumonia; Treatment Outcome; Young Adult | 2012 |
Bronchiolitis obliterans organizing pneumonia (BOOP) after renal transplantation.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Methylprednisolone; Pneumonia; Prednisone; Tomography, X-Ray Computed | 2013 |
An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Disease Management; Female; Guideline Adherence; Hospitalization; Humans; Male; Medical Audit; Middle Aged; Oman; Pneumonia; Practice Guidelines as Topic; Quality of Health Care; Retrospective Studies; Severity of Illness Index | 2012 |
Clarithromycin for community-acquired pneumonia: beware drug interactions.
Topics: Aged; Clarithromycin; Community-Acquired Infections; Drug Interactions; Humans; Pneumonia; Retrospective Studies | 2012 |
Assessment of antibiotic prescribing in Latvian general practitioners.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Child; Child, Preschool; Clarithromycin; Drug Prescriptions; Female; General Practice; Humans; Infant; Latvia; Male; Middle Aged; Pharyngitis; Pneumonia; Practice Patterns, Physicians'; Sinusitis; Surveys and Questionnaires; Urinary Tract Infections; Young Adult | 2013 |
[Severe multiorgan psittacosis in a 10-year-old boy].
Topics: Abdomen, Acute; Anti-Bacterial Agents; Child; Clarithromycin; Diagnosis, Differential; Fever; Humans; Male; Pneumonia; Psittacosis; Renal Insufficiency; Shock | 2002 |
Fulminant liver failure associated with clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Humans; Liver Failure; Liver Function Tests; Middle Aged; Pneumonia | 2003 |
[Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin].
Topics: Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Decision Trees; Economics, Pharmaceutical; Humans; Ketolides; Macrolides; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies | 2003 |
Appropriate antibiotic utilization in seniors prior to hospitalization for community-acquired pneumonia is associated with decreased in-hospital mortality.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Prescriptions; Drug Utilization; Female; Hospital Mortality; Hospitalization; Humans; Male; Odds Ratio; Pneumonia; Preventive Health Services; Retrospective Studies; Sulfamethoxazole; Survival Rate; Trimethoprim | 2004 |
Simvastatin interaction with clarithromycin and amiodarone causing myositis.
Topics: Amiodarone; Clarithromycin; Coronary Artery Bypass; Drug Interactions; Humans; Male; Middle Aged; Myositis; Pneumonia; Simvastatin; Tachycardia, Supraventricular | 2005 |
[Organizing pneumonia--own experiences with clarithromycin treatment].
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Middle Aged; Pneumonia; Treatment Outcome | 2004 |
[Assessment of the management of community-acquired pneumonia in adults outpatients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Emergencies; Female; Frail Elderly; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Treatment Failure | 2005 |
Pneumonitis after inhalation of mercury vapours.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cefuroxime; Chelating Agents; Chelation Therapy; Clarithromycin; Humans; Male; Mercury Poisoning; Pneumonia; Radiography; Self-Injurious Behavior; Succimer; Volatilization | 2006 |
[Antibiotics, purpura and ulcers: a leukocytoclastic vasculitis after clarithromycin].
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; IgA Vasculitis; Middle Aged; Pneumonia; Skin Ulcer; Vasculitis, Leukocytoclastic, Cutaneous | 2006 |
Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; North America; Pneumonia; Prospective Studies; Sputum; Streptococcus pneumoniae | 2007 |
Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Heart Transplantation; Humans; Lung Diseases; Male; Nocardia Infections; Pneumonia; Postoperative Complications | 2007 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia | 1994 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Pneumonia; Postoperative Complications; Sulfisoxazole | 1993 |
Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous System Diseases; Clarithromycin; Drug Interactions; Female; Humans; Male; Middle Aged; Pneumonia; Psychotic Disorders | 1997 |
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Clarithromycin; Complement C3; Female; Glomerulonephritis; Humans; Kidney Glomerulus; Pneumonia; Pneumonia, Mycoplasma; Renal Dialysis | 1998 |
Torsade de pointes induced by cisapride/clarithromycin interaction.
Topics: Aged; Anti-Bacterial Agents; Cisapride; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Gastrointestinal Agents; Humans; Mixed Function Oxygenases; Nausea; Pneumonia; Torsades de Pointes | 1999 |
[Can macrolide treatment delay the diagnosis of tuberculosis?].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Humans; Pneumonia; Time Factors; Tuberculosis, Pulmonary | 1999 |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Clarithromycin; Doxycycline; Female; Mycobacterium; Pneumonia; Rifampin | 1999 |
Henoch-Schönlein purpura induced by clarithromycin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Humans; IgA Vasculitis; Pneumonia; Skin Diseases | 1999 |
How to manage the low-risk patient with lower respiratory tract infection?
Topics: Ambulatory Care; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia; Risk Factors | 1999 |
[Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clarithromycin; Community-Acquired Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Risk Factors; Smoking; Time Factors | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host].
Topics: Aged; Amikacin; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Immunocompromised Host; Male; Nocardia; Nocardia Infections; Pneumonia; Treatment Outcome | 2000 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etodolac; Lung Neoplasms; Male; Nitrosamines; Pneumonia; Rats; Rats, Wistar | 2001 |
New macrolide antibiotics.
Topics: Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia | 1992 |
[Clarithromycin in the treatment of respiratory infections].
Topics: Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Pneumonia; Respiratory Tract Infections | 1991 |
[Mycobacterium chelonei pulmonary infections. Apropos of a case].
Topics: Clarithromycin; Erythromycin; Female; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pneumonia; Tomography, X-Ray Computed | 1991 |